Efficacy and safety results from GEICO 1205, a randomized phase II trial of neoadjuvant chemotherapy with or without bevacizumab for advanced epithelial ovarian cancer

  1. Garcia, Y.G.
  2. De Juan Ferré, A.
  3. Mendiola, C.
  4. Barretina-Ginesta, M.-P.
  5. Gaba Garcia, L.
  6. Santaballa Bertrán, A.
  7. Bover Barcelo, I.
  8. Gil-Martin, M.
  9. Manzano, A.
  10. Pérez, M.J.R.
  11. Romeo Marin, M.
  12. Arqueros Núñez, C.
  13. García-Martínez, E.
  14. Gonzalez Martin, A.
Journal:
International Journal of Gynecological Cancer

ISSN: 1525-1438 1048-891X

Year of publication: 2019

Volume: 29

Issue: 6

Pages: 1050-1056

Type: Article

DOI: 10.1136/IJGC-2019-000256 GOOGLE SCHOLAR

Sustainable development goals